Abstract
Purpose
This study aimed to compare the radiological tumor (T)-category using multiparametric MRI with the pathological T category in patients with oral tongue squamous cell carcinoma (OTSCC) and to examine which is a better predictor of prognosis.
Methods
This retrospective study included 110 consecutive patients with surgically resected primary OTSCC who underwent preoperative contrast-enhanced MRI. T categories determined by maximum diameter and depth of invasion were retrospectively assessed based on the pathological specimen and multiparametric MRI. The MRI assessment included the axial and coronal T1-weighted image (T1WI), axial T2-weighted image (T2WI), coronal fat-suppressed T2WI, and axial and coronal fat-suppressed contrast-enhanced T1WI (CET1WI). Axial and coronal CET1WI measurements were divided into two groups: measurements excluding peritumoral enhancement (MEP) and measurements including peritumoral enhancement. The prognostic values for recurrence and disease-specific survival after radiological and pathological T categorization of cases into T1/T2 and T3/T4 groups were compared.
Results
The T category of MEP on coronal CET1WI was the most relevant prognostic factor for recurrence [hazard ratio (HR) = 3.30, p = 0.001] and the HR was higher than the HR for pathological assessment (HR = 2.26, p = 0.026). The T category determined by MEP on coronal CET1WI was also the most relevant prognostic factor for disease-specific survival (HR = 3.12, p = 0.03), and the HR was higher than the HR for pathological assessment (HR = 2.02, p = 0.20).
Conclusion
The T category determined by MEP on the coronal CET1WI was the best prognostic factor among all radiological and pathological T category measurements.
Similar content being viewed by others
Explore related subjects
Find the latest articles, discoveries, and news in related topics.Avoid common mistakes on your manuscript.
Introduction
Oral tongue squamous cell carcinoma (OTSCC) is the eighth most common cancer worldwide [1, 2]. OTSCC accounts for more than 90% of all oral malignancies and is more prevalent in males than females [1, 3]. Even in early-stage disease, tumors recur in 10–25% of cases. In advanced staged disease, the rate of tumor recurrence is approximately 40–60% of cases [4]. According to the eighth edition of the American Joint Committee on Cancer (AJCC) staging manual, T categorization of OTSCC is defined by the maximum diameter and depth of invasion (DOI). A DOI of OTSCC greater than 5 mm and 10 mm is recommended as the gold standard threshold for T1–T3 staging and preventive dissection as follows: T1, tumor ≤ 2 cm with DOI ≤ 5 mm; T2, tumor ≤ 2 cm with DOI > 5 mm and ≤ 10 mm or tumor > 2 cm but ≤ 4 cm with DOI ≤ 10 mm; T3, tumor > 4 cm or any tumor size with DOI > 10 mm. Follow-up after treatment should be considered in cases of OTSCC with DOIs exceeding 5 mm [2, 5,6,7]. The precise and reproducible measurement of pathological DOI is essential because as lack of adherence to a uniform definition can significantly affect accurate staging; however, the measurement of pathological DOI is sometimes difficult for various reasons [7].
In recent years, the relationship between pathological and radiological DOI has been investigated in many studies and several meta-analyses. Radiological DOI is generally 2–3 mm larger than pathological DOI, resulting in overestimating the clinical T staging [2, 5, 8,9,10,11,12,13,14,15,16,17,18]. The overestimation of radiological DOI is caused by severe local inflammation, peritumoral edema, and local tissue swelling after having a biopsy [9, 10, 16]. In these studies, the gold standard for T staging of OTSCC is based on pathological assessment, and radiological DOI or radiology-based T staging correlates with the pathological referenced standard. However, up to 30% shrinkage of soft tissue may occur after formalin fixation; therefore, the pathological T category is derived from the actual measurement of unfixed tumor in the resected specimen [19]. We thought that radiology-based T staging might be more useful in predicting prognosis than pathological T staging. In addition, the appropriate MRI sequence and imaging plane for the measurement of the maximum radiological diameter and DOI have not been established. To the best of our knowledge, no study has compared pathological T staging with radiological T staging for the ability to predict OTSCC for predicting tumor recurrence and patient survival. Thus, this study aimed to compare the prognostic value of radiological T categorization using multiparametric MRI with pathological T categorization in patients with OTSCC.
Methods
Patients
The present study was approved by the human research committee of the institutional review board of our hospital and complies with the guidelines of the Health Insurance Portability and Accountability Act of 1996 and the Declaration of Helsinki. the requirement for informed consent was waived due to the retrospective nature of the study. Consecutive patients with histologically proven OTSCC who underwent preoperative contrast-enhanced MRI between January 2007 and August 2022 were identified using the electronic medical record system at our hospital. The following inclusion criteria were applied: (1) gross total resection, (2) histologically diagnosed cases, and (3) preoperative MRI, including axial T1-weighted image (T1WI), axial T2-weighted image (T2WI), axial fat-suppressed contrast-enhanced T1WI (CET1WI), coronal T1WI, coronal fat-suppressed T2WI, and coronal CET1WI. The exclusion criteria were as follows: (1) prior history of head and neck squamous cell carcinoma, (2) invasion of adjacent structures (cortical bone, skin, masticator space, pterygoid plates, skull base, or internal carotid artery), and (3) inappropriate image quality for evaluation.
Pathological assessment
A pathologist with 7 years of post-training experience in the pathological diagnosis of OSTCC reviewed all histological specimens based on the eighth edition of the AJCC staging manual and determined the T category based on the maximum diameter and DOI. DOI was defined as measurement from the level of the basement membrane of the closet adjacent normal mucosa to the deepest point of invasion [7, 20].
MRI imaging
All patients underwent unenhanced and enhanced MRI using a 1.5-T-MRI system (Intera Achieva 1.5 T Pulsar; Philips Medical Systems, Best, The Netherlands) or a 3.0 T-MRI system (Intera Achieva 3.0 T Quasar Dual; Philips Medical Systems, Best, The Netherlands). All MR images were obtained at a section thickness of 3–4 mm with 1-mm intersection gap and a 20 × 20–26 × 26-cm field of view. Axial and coronal T1WIs (TR/TE, 609–827/9–18 ms), axial T2WIs (TR/TE, 3398–5709/90 ms), and coronal fat-suppressed T2WIs (TR/TE, 3330–6670/60–90 ms) were obtained. Axial and coronal fat-suppressed CET1WIs (TR/TE, 630–756/9–18 ms) were obtained after the intravenous injection of 0.1 mmol/kg of gadopentetate dimeglumine (Magnevist, Bayer HealthCare, Leverkusen, Germany) or gadobutrol (Gadavist, Bayer HealthCare, Leverkusen, Germany).
Imaging assessment
Two radiologists with 23 and 9 years of post-training experience in head and neck imaging reviewed all the images individually. The radiologists were unaware of the clinical information and pathological diagnoses.
The reviewers measured the maximum diameter and DOI on the axial T1WI, axial T2WI, axial CET1WI, coronal T1WI, coronal fat-suppressed T2WI, and coronal CE-T1WI. The maximum diameter and DOI were measured from axial and coronal images and the average value measured by the two radiologists was used.
The DOI was measured at the deepest infiltration point on each image. The DOI was measured from the level of the mucosal surface adjacent to the tumor to the deepest point of tumor invasion [9]. The maximum diameter and DOI on the axial and coronal CET1WI were divided into two groups: measurements including peritumoral enhancement (MIP) and measurements excluding peritumoral enhancement (MEP) (Fig. 1). Peritumoral enhancement was defined as a peripheral stronger enhanced area compared with a less enhanced central area on CET1WI. The less enhanced central area on CET1WI is generally consistent with tumor size on the other sequences. If peritumoral enhancement was not observed, MIP was recorded as the same value as MEP. The maximum diameter and DOI on T1WI and CET1WI were assessed using both the axial and coronal planes; therefore, the greater value was used as the maximum diameter and DOI on the combined axial and coronal images. Finally, T categories were determined for each imaging sequence according to the eighth edition of the AJCC staging manual.
a Axial fat-suppressed contrast-enhanced T1-weighted image shows the measurement of the maximum diameter determined by MEP (solid line) and MIP (dotted line). b Coronal fat-suppressed contrast-enhanced T1-weighted image shows the measurement of the depth of invasion determined by MEP (solid line) and MIP (dotted line). Right submandibular nodal metastasis is shown (arrow). c Histological specimen (H&E stain; scale bar, 5 mm) shows tongue cancer in the central areas (star) and inflammation, vascular enlargement, or edema in the peripheral areas (asterisk)
Statistical analysis
All statistical analyses were performed using SPSS version 24.0 (IBM Corp., Armonk, NY, USA). The correlations of radiological and pathological measurements were assessed by Pearson’s correlation coefficient. Interobserver variability of qualitative assessments between two radiologists was assessed using kappa statistics. The frequency of histologically proven cervical nodal metastasis was compared by Fisher’s exact test between T1/2 and T3/4 cases. The odds ratio and 95% confidence intervals (CIs) of predictive factors for diagnosing lymph node metastasis were calculated by logistic regression models. Log-rank test and Cox proportional hazard regression were conducted for univariate and multivariate analysis to evaluate prognostic factors for recurrence and disease-specific survival between T1/2 and T3/4 cases. p values < 0.05 were considered significant.
Results
We found 130 patients with OTSCC after pathological examination and 20 patients excluded (16 patients with inadequate MRI image and 5 with prior history of head and neck squamous cell carcinoma). This study included 110 patients with OTSCC (71 men; age range, 23–90 years; mean age, 62 years). Thirty-two, 51, 22, and 5 patients were classified into T1, T2, T3, and T4 OTSCC T categories, respectively. Thirty-six patients (33%) had histologically proven cervical nodal metastases and no patient had distant metastasis on initial treatment. All patients had grossly complete removal of the primary tumor and lymph node metastasis at initial surgery. Thirty-nine (35%), 26 (24%), and 59 (54%) patients received chemotherapy, radiation therapy, and radical neck dissection, respectively. Thirty-two patients (29%) experienced recurrence after surgery and 16 (15%) patients died of OTSCC. The median follow-up period was 1315 days (interquartile range [IQR]: 562–2553 days).
The maximum diameters and DOIs are summarized in Table 1.
The median pathological maximum diameter and DOI were 16.6 mm (IQR: 22.0–33.0) and 6.5 mm (IQR: 3.1–10.8), respectively. The median radiological maximum diameters on the axial, coronal, and combined axial/coronal images were 16.0–18.6 mm, 14.2–16.1 mm, and 17.0–19.4 mm, respectively. The radiological DOIs on the axial, coronal, and axial/coronal images were 9.5–10.6 mm, 9.1–10.9 mm, and 9.8–11.0 mm, respectively. Pearson’s coefficients between the pathological and radiological maximum diameters and DOIs were 0.19–0.37 and 0.79–0.85, respectively. The Kappa value for interobserver agreement between the two radiologists ranged from 0.59 to 0.75.
The relationship between histologically proven cervical nodal metastasis and the T category is summarized in Table 2. Among all radiological and pathological assessments, the frequency of cervical nodal metastasis was significantly higher in T3/T4 compared with the frequency in T1/T2 (p < 0.01). The odds ratio for pathological T category was 4.58 (95%CI; 1.83–11.5), and the odds ratios for the radiological T category ranged from 5.36 to 13.0.
The univariable analysis of prognostic factors for recurrence is summarized in Table 3. Significant prognostic factors for recurrence included pathologic T category [hazard ratio (HR); 2.23, p = 0.03], axial CET1WI-MEP (2.10, p = 0.04), coronal T1WI (2.84, p < 0.01), coronal FST2WI (2.26, p = 0.02), coronal CET1WI-MEP (3.30, p < 0.01), and combined axial/coronal T1WI (2.14, p = 0.03) (Fig. 2). However, multivariate analysis revealed no significant prognostic factor for recurrence.
The univariable analysis of prognostic factors for disease-specific survival and overall survival is summarized in Table 4 and 5. The only significant prognostic factor for disease-specific survival was the T category on coronal CET1WI-MEP (HR; 3.20, p = 0.03). The pathological T category was not a significant prognostic factor for disease-specific survival (HR; 2.02, p = 0.20) (Fig. 3). However, multivariate analysis revealed no significant prognostic factor for disease-specific survival. No significant prognostic factor for overall survival was observed.
Discussion
The T category determined based on the coronal CET1WI-MEP was the most relevant prognostic factor for tumor recurrence (HR, 3.30), and the HR for coronal CET1WI-MEP was higher than the HR based on the pathological assessment (HR, 2.26). The T category of coronal CET1WI-MEP was also the most relevant prognostic factor for disease-specific survival (HR, 3.12), and the HR for coronal CET1WI-MEP was higher than the HR for pathological assessment (HR, 2.02).
The radiological DOI on CET1WI-MEP and CET1WI-MIP correlated the best with the pathological assessment. In previous studies, the correlations between radiological and pathological DOI varied considerably. Tang et al. reported that CET1WI was slightly more accurate than T2WI [2]. Baba et al. reported that T1WI had the most accurate correlation, followed by CET1WI and T2WI [8]. Takamura et al. reported that axial CET1WI was more accurate than axial T2WI, and coronal T2WI was more accurate than coronal CET1WI [5]. These variations may stem from the different imaging planes used for the evaluations, only the axial plane, only the coronal plane, and the combined axial and coronal planes.
In the present study, the radiological DOI measured from coronal images tended to correlate better with the pathological DOI than the DOI from axial or combined axial/coronal images. Although many studies evaluated the radiological DOI using both axial and coronal images [8, 9, 21], few studies compared radiological DOI between axial and coronal images [5]. No consensus concerning the optimal imaging plane for evaluating radiological DOI and maximum diameter has been reached. Takamura et al. reported that the mean DOI measured on the coronal CET1WI and T2WI correlated better with the pathological DOI than the DOI measured on the axial CET1WI and T2WI (0.79–0.83 vs. 0.66–0.73) [5]. This difference may arise because the specimen is excised in the cross-section closest to the coronal section [5]. Our results are similar to those of the previous study because the pathological specimen in this study was also excised in the coronal section. Therefore, the radiological maximum diameter and DOI of coronal images should correlate best with the pathological maximum diameter and DOI.
Although the correlation coefficients for CET1WI-MEP and CET1WI-MIP with the pathological-radiological measurements were similar, CET1WI-MEP was superior to CET1WI-MIP for predicting recurrence and disease-specific survival. Histopathologically, peritumoral enhancement may be caused by edematous changes and reactive inflammation in the surrounding tissue [5, 22]. Many studies reported the assessment of the maximum diameter and DOI [2, 5, 8, 10, 21, 23, 24]; however, there is no investigation whether the radiological maximum diameter and DOI include peritumoral enhancement. The maximum diameter and DOI may be overestimated when peritumoral enhancement is included; therefore, the radiological maximum diameter and DOI should exclude peritumoral enhancement.
The T category based on the coronal CET1WI-MEP was a more relevant prognostic factor for recurrence than the T category based on pathological assessment. Pathological assessment incurs several problems. First, the oral tongue has a curved natural surface, and drawing an arbitrary straight line from the basement membrane of adjacent normal squamous epithelium may significantly underestimate the actual DOI [20]. Second, the pathological maximum diameter and DOI are measured from each section; however, in some cases, adjacent normal squamous mucosa is not present horizontally in the pathological specimen with the deepest level of invasion or in the entire specimen, or the adjacent uninvolved epithelium is present only on one side of the tumor section [7, 20]. Third, accurate assessment of the horizon is difficult in tumors where the natural contour of the epithelium is not uniform or straight [7]. Fourth, tongue tissue specimens are prone to distortion during handling [25]. Lastly, the section thickness of MRI is finer than the thickness of histological slides [25]. In contrast, the radiological maximum diameter and DOI can be measured by observing the whole tumor. Thus, radiological measurements may be more accurate than pathological measurements. This is the first study to determine the prognostic factor among pathological and radiological T staging using Kaplan–Meier survival analysis. However, further investigation is required.
Radiomics is a valuable tool for predicting prognosis for OTSCC; therefore, there is a paradigm shift to include radiomics to predict survival in OTSCC. A past study provides a new approach for OTSCC treatment management using a combined model based on clinical features and MRI radiomic parameters and concluded that the radiological T category was superior to the pathological T category in predicting prognosis [26]. Thus, if the true prognostic value of radiomics can be revealed, radiomics would become increasingly important in the future.
This study has several limitations. First, the cohort included a moderately small number of cases because the present study was conducted at a single institution; therefore, this study could not compare prognostic factors using stratifies cohort of patients with all T scores with and without metastases. Second, the maximum diameter and DOI on the combined axial/coronal T2WI or FST2WI could not be evaluated as coronal T2WI and axial FST2WI were not performed at our institution at the time of this study. Third, this study included patients with and without cervical nodal metastases. Fourth, disease-specific survival rates and overall survival were calculated in this study; however, we could not evaluate relative survival because of a lack of sufficient statistical knowledge. Finally, only two-dimensional MRI images were obtained in this study. If three-dimensional MRI images were used for evaluation, the maximum diameter and DOI could be measured more accurately.
In conclusion, the T category determined by MEP on coronal CET1WI was the best validated prognostic factor among all radiological and pathological T category measurements. Peritumoral enhancement on CET1WI should be excluded when measuring the radiological maximum diameter and DOI as the T category based on MEP was more strongly associated with patient prognosis than the T category based on MIP.
References
Siegel RL, Miller KD, Wagle NS (2023) Jemal A (2023) Cancer statistics. CA Cancer J Clin 73(1):17–48. https://doi.org/10.3322/caac.21763
Tang W, Wang Y, Yuan Y, Tao X (2022) Assessment of tumor depth in oral tongue squamous cell carcinoma with multiparametric MRI: correlation with pathology. Eur Radiol 32(1):254–261. https://doi.org/10.1007/s00330-021-08148-6
Badwelan M, Muaddi H, Ahmed A, Lee KT, Tran SD (2023) Oral squamous cell carcinoma and concomitant primary tumors, what do we know? A Review of the Literature. Curr Oncol 30(4):3721–3734. https://doi.org/10.3390/curroncol30040283
Zittel S, Moratin J, Horn D, Metzger K, Ristow O, Engel M, Mrosek J, Freier K, Hoffmann J, Freudlsperger C (2022) Clinical outcome and prognostic factors in recurrent oral squamous cell carcinoma after primary surgical treatment: a retrospective study. Clin Oral Invest 26(2):2055–2064. https://doi.org/10.1007/s00784-021-04186-y
Takamura M, Kobayashi T, Nikkuni Y, Katsura K, Yamazaki M, Maruyama S, Tanuma JI, Hayashi T (2022) A comparative study between CT, MRI, and intraoral US for the evaluation of the depth of invasion in early stage (T1/T2) tongue squamous cell carcinoma. Oral Radiol 38(1):114–125. https://doi.org/10.1007/s11282-021-00533-7
Hiyama T, Kuno H, Sekiya K, Tsushima S, Oda S, Kobayashi T (2022) Subtraction iodine imaging with area detector CT to improve tumor delineation and measurability of tumor size and depth of invasion in tongue squamous cell carcinoma. Jpn J Radiol 40(2):167–176. https://doi.org/10.1007/s11604-021-01196-4
Kukreja P, Parekh D, Roy P (2020) Practical challenges in measurement of depth of invasion in oral squamous cell carcinoma: pictographical documentation to improve consistency of reporting per the AJCC 8th Edition Recommendations. Head Neck Pathol 14 (2):419–427. https://doi.org/10.1007/s12105-019-01047-9
Baba A, Okuyama Y, Yamauchi H, Ikeda K, Ogino N, Kozakai A, Suzuki T, Saito H, Ogane S, Yamazoe S, Mogami T, Ojiri H (2019) Magnetic resonance imaging findings of styloglossus and hyoglossus muscle invasion: relationship to depth of invasion and clinical significance as a predictor of advisability of elective neck dissection in node negative oral tongue cancer. Eur J Radiol 118:19–24. https://doi.org/10.1016/j.ejrad.2019.06.023
Waech T, Pazahr S, Guarda V, Rupp NJ, Broglie MA, Morand GB (2021) Measurement variations of MRI and CT in the assessment of tumor depth of invasion in oral cancer: a retrospective study. Eur J Radiol 135:109480. https://doi.org/10.1016/j.ejrad.2020.109480
Mao MH, Wang S, Feng ZE, Li JZ, Li H, Qin LZ, Han ZX (2019) Accuracy of magnetic resonance imaging in evaluating the depth of invasion of tongue cancer. A prospective cohort study Oral Oncol 91:79–84. https://doi.org/10.1016/j.oraloncology.2019.01.021
Terada H, Sasaki E, Suzuki H, Nishikawa D, Beppu S, Hanai N (2020) An examination of the cutoff value of the depth of invasion for prophylactic neck dissection in stage I/II tongue cancer. Acta Otolaryngol 140(5):422–426. https://doi.org/10.1080/00016489.2020.1717606
Baba A, Okuyama Y, Ikeda K, Kozakai A, Suzuki T, Saito H, Ogane S, Yamazoe S, Yamauchi H, Ogino N, Seto Y, Kobashi Y, Mogami T, Ojiri H (2019) Undetectability of oral tongue cancer on magnetic resonance imaging; clinical significance as a predictor to avoid unnecessary elective neck dissection in node negative patients. Dentomaxillofac Radiol 48(3):20180272. https://doi.org/10.1259/dmfr.20180272
Alsaffar HA, Goldstein DP, King EV, de Almeida JR, Brown DH, Gilbert RW, Gullane PJ, Espin-Garcia O, Xu W, Irish JC (2016) Correlation between clinical and MRI assessment of depth of invasion in oral tongue squamous cell carcinoma. J Otolaryngol Head Neck Surg 45(1):61. https://doi.org/10.1186/s40463-016-0172-0
Voizard B, Khoury M, Saydy N, Nelson K, Cardin GB, Létourneau-Guillon L, Filali-Mouhim A, Christopoulos A (2023) Preoperative evaluation of depth of invasion in oral tongue squamous cell carcinoma: a systematic review and meta-analysis. Oral Oncol 136:106273. https://doi.org/10.1016/j.oraloncology.2022.106273
Lee MK, Choi Y (2023) Correlation between radiologic depth of invasion and pathologic depth of invasion in oral cavity squamous cell carcinoma: a systematic review and meta-analysis. Oral Oncol 136:106249. https://doi.org/10.1016/j.oraloncology.2022.106249
Das R, Misra SR (2023) Magnetic resonance imaging in the preoperative evaluation of depth of invasion in oral squamous carcinoma tongue: a few points to consider! Oral Oncol 139:106337. https://doi.org/10.1016/j.oraloncology.2023.106337
Zhang YY, Chu DG, Mao MH, Feng ZE, Li JZ, Qin LZ, Han ZX (2022) The role of magnetic resonance imaging in assessing the extent of tongue squamous cell carcinoma: a prospective cohort study. J Stomatol Oral Maxillofac Surg 123(6):e822–e827. https://doi.org/10.1016/j.jormas.2022.03.006
Li M, Yuan Z, Tang Z (2022) The accuracy of magnetic resonance imaging to measure the depth of invasion in oral tongue cancer: a systematic review and meta-analysis. Int J Oral Maxillofac Surg 51(4):431–440. https://doi.org/10.1016/j.ijom.2021.07.010
Mohiyuddin SMA, Padiyar BV, Suresh TN, Mohammadi K, Sagayaraj A, Merchant S, Sultana Azeem M (2016) Clinicopathological study of surgical margins in squamous cell carcinoma of buccal mucosa. World J Otorhinolaryngol Head Neck Surg 2(1):17–21. https://doi.org/10.1016/j.wjorl.2016.02.003
Salama AM, Valero C, Katabi N, Khimraj A, Yuan A, Zanoni DK, Ganly I, Patel SG, Ghossein R, Xu B (2021) Depth of invasion versus tumour thickness in early oral tongue squamous cell carcinoma: which measurement is the most practical and predictive of outcome? Histopathology 79(3):325–337. https://doi.org/10.1111/his.14291
Weimar EAM, Huang SH, Lu L, O'Sullivan B, Perez-Ordonez B, Weinreb I, Hope A, Tong L, Goldstein D, Irish J, de Almeida JR, Bratman S, Xu W, Yu E (2018) Radiologic-pathologic correlation of tumor thickness and its prognostic importance in squamous cell carcinoma of the oral cavity: implications for the eighth edition tumor, node, metastasis classification. AJNR Am J Neuroradiol 39 (10):1896–1902 https://doi.org/10.3174/ajnr.A5782
Prabhu AV, Sturgis CD, Lai C, Maxwell JH, Merzianu M, Hernandez-Prera JC, Purgina B, Thompson LDR, Tuluc M, Yang X, Seethala RR, Ferris RL, Chiosea SI (2017) Improving margin revision: characterization of tumor bed margins in early oral tongue cancer. Oral Oncol 75:184–188. https://doi.org/10.1016/j.oraloncology.2017.10.013
Fu JY, Zhu L, Li J, Chen PQ, Shi WT, Shen SK, Zhang CP, Zhang ZY (2021) Assessing the magnetic resonance imaging in determining the depth of invasion of tongue cancer. Oral Dis 27(3):457–463. https://doi.org/10.1111/odi.13579
Murakami R, Shiraishi S, Yoshida R, Sakata J, Yamana K, Hirosue A, Uchiyama Y, Nakayama H, Yamashita Y (2019) Reliability of MRI-derived depth of invasion of oral tongue cancer. Acad Radiol 26(7):e180–e186. https://doi.org/10.1016/j.acra.2018.08.021
Koivuholma A, Aro K, Mäkitie A, Salmi M, Mirtti T, Hagström J, Atula T (2021) Three-dimensional presentation of tumor histopathology: a model using tongue squamous cell carcinoma. Diagnostics (Basel) 11 (1) https://doi.org/10.3390/diagnostics11010109
Liu J, Song L, Zhou J, Yu M, Hu Y, Zhang J, Song P, Ye Y, Wang J, Feng G, Guo H, An P (2023) Prediction of prognosis of tongue squamous cell carcinoma based on clinical MR imaging data modeling. Technol Cancer Res Treat 22:15330338231207006. https://doi.org/10.1177/15330338231207006
Funding
Open Access funding provided by Gifu University.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethical approval
All procedures performed in the studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparableethical standards.
Informed consent
The requirement for informed consent was waived due to the retrospective nature of this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kawaguchi, M., Kato, H., Kanayama, T. et al. Prognostic value of radiological T category using conventional MRI in patients with oral tongue cancer: comparison with pathological T category. Neuroradiology 66, 907–917 (2024). https://doi.org/10.1007/s00234-024-03345-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00234-024-03345-8